top of page



Our products will initially target the point-of-care (POC) and physician’s office laboratory (POL) market segments within the domestic and international in vitro diagnostics device market, with expansion predicted into retail pharmacy/over-the-counter (OTC), clinical labs, and Health Care Associations. Our customers will include physicians, hospitals, emergency rooms, wholesale distributors, and pharmacies.


Market Strategy

Our products have been designed to offer a clear-cut differentiation with currently available tests for monitoring diabetes, kidney function and coagulation.

  • Lower cost

  • User convenience

  • Value of information

  • Facilitation of doctor-patient feedback

  • Therapeutic intervention










bottom of page